Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion type Assertion NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_head.
- NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion wasGeneratedBy ECO_0000203 NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_provenance.
- NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion wasDerivedFrom befree-20150227 NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_provenance.
- NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion SIO_000772 24195468 NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_provenance.
- NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion evidence source_evidence_literature NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_provenance.
- NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_assertion description "[Serum sialyl Lewis X antigen level increased when the adenocarcinoma component was dominant, whereas plasma pro-gastrin-releasing peptide level increased when the small-cell lung cancer component became dominant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414669.RAUkH9gtGrRPGlcMsWgNHH4AlFPsOKhuFo_U5xIiFyeOM130_provenance.